Literature DB >> 26294728

Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Alexandra M Stevens1, Marcos J Ruiz2, Robert B Gerbing3, Todd A Alonzo4, Alan S Gamis5, Michele S Redell2.   

Abstract

Entities:  

Keywords:  STAT3; acute myeloid leukemia; ligand stimulation; pediatric; relapse

Mesh：

Substances：

Year:  2015        PMID： 26294728      PMCID： PMC4666340          DOI： 10.3324/haematol.2015.131508

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity.

Authors:  J Braess; S Voss; G Jahns-Streubel; C Schoch; T Haferlach; W Kern; S Keye; E Schleyer; W Hiddemann
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

Authors:  Mustafa Benekli; Zheng Xia; Kathleen A Donohue; Laurie A Ford; Lynda A Pixley; Maria R Baer; Heinz Baumann; Meir Wetzler
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction.

Authors:  J Schmitz; H Dahmen; C Grimm; C Gendo; G Müller-Newen; P C Heinrich; F Schaper
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 4.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 5.  STAT signaling in the pathogenesis and treatment of leukemias.

Authors:  T S Lin; S Mahajan; D A Frank
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

6.  Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.

Authors:  J J Schuringa; A T Wierenga; W Kruijer; E Vellenga
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

7.  Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

Authors:  Alan S Gamis; Todd A Alonzo; Soheil Meshinchi; Lillian Sung; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Samir B Kahwash; Amy Heerema-McKenney; Laura Winter; Kathleen Glick; Stella M Davies; Patti Byron; Franklin O Smith; Richard Aplenc
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

8.  Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Authors:  Bob Löwenberg; Wim van Putten; Matthias Theobald; Jurg Gmür; Leo Verdonck; Pieter Sonneveld; Martin Fey; Harry Schouten; Georgine de Greef; Augustin Ferrant; Tibor Kovacsovics; Alois Gratwohl; Simon Daenen; Peter Huijgens; Marc Boogaerts
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

9.  Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.

Authors:  Beatriz Sanchez-Correa; Juan M Bergua; Carmen Campos; Inmaculada Gayoso; Maria Jose Arcos; Helena Bañas; Sara Morgado; Javier G Casado; Rafael Solana; Raquel Tarazona
Journal:  Cytokine       Date:  2013-01-26       Impact factor: 3.861

10.  Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.

Authors:  Tasnim Ara; Rie Nakata; Michael A Sheard; Hiroyuki Shimada; Ralf Buettner; Susan G Groshen; Lingyun Ji; Hua Yu; Richard Jove; Robert C Seeger; Yves A DeClerck
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701
View more
  1 in total

1.  Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance.

Authors:  Alexandra M Stevens; Jennifer M Miller; Jaime O Munoz; Amos S Gaikwad; Michele S Redell
Journal:  Blood Adv       Date:  2017-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.